Industry

DUBLIN–(BUSINESS WIRE)–The “CAR-T Therapy Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global CAR-T therapy market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The market is expected to grow to $3.55 billion in 2026 at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Processing Seals Global Market Report 2022, By Type, Material, Application” report has been added to ResearchAndMarkets.com’s offering. The global pharmaceutical processing seals market is expected to grow from $1.80 billion in 2021 to $2.03 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to … [Read more…]

MALVERN, Pa.–(BUSINESS WIRE)–DSG, Inc., a global leader of eClinical software solutions and services, along with 1nHealth, a global digital patient recruitment provider, are creating a seamless participant experience from the initial study launch to completion of study participation. This includes integrating pre-screened leads from 1nHealth’s secure platform into DSG’s eCaseLink Enrollment Tracker to allow participants … [Read more…]

New all-flash data platform enables global genetic data analytics factory to quickly make discoveries from massive volumes of genomics sequence data, fueling medical breakthroughs Remote-First-Company/NEW YORK–(BUSINESS WIRE)–VAST Data, the data platform company for the AI-powered world, today announced the company was selected by CeGaT to accelerate time-to-insight for genetic analytics essential to diagnostic healthcare, genetic … [Read more…]

Ozette’s proprietary technology eliminates manual gridlock and provides unmatched speed, resolution, and reproducibility to unlock immunotherapy breakthroughs from pre-clinical to post-market. SEATTLE–(BUSINESS WIRE)–Ozette Technologies, Inc., a technology-driven life sciences startup engineering a transformative leap in cell discovery and annotation of the human immune system, today announced its $26MM Series A funding, led by Madrona Ventures. … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report second quarter financial results on Thursday, August 4, 2022. That same day, Mirum will host a conference call to discuss the company’s progress and priorities for 2022. Conference call details: Thursday, August 4, 2022 4:30 p.m. ET / 1:30 p.m. PT … [Read more…]

Five Scientific Publications Underscores Proenzymes as an Effective Tool to Treat and Prevent Metastatic Cancer from Solid Tumors with Further Research in Progress MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that Chief Scientific Officer … [Read more…]

NEWTON, Mass.–(BUSINESS WIRE)–Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has acquired 47071 Bayside Parkway located in Fremont, CA for $82 million, excluding closing costs, reflecting a current GAAP cap rate of 6.5% at closing. The recently renovated asset includes 89,000 rentable square feet of lab and corporate headquarters space that is 100% leased … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent. Effective immediately, Michael Prosser is promoted to Chief Business Officer. Michael has been with Crown Bioscience for over ten years … [Read more…]

BOSTON–(BUSINESS WIRE)–Silversmith Capital Partners (“Silversmith”) today announced the first and final close of its fourth fund, Silversmith Capital Partners IV (“Fund IV”). Launched in May 2022, Fund IV was significantly oversubscribed and closed at its target and hard cap of $1.25 billion. In addition to the $1.25 billion from limited partners, the Silversmith team will … [Read more…]